Blogs

Rituximab in childhood and juvenile autoimmune bullous diseases as first-line and second-line treatment: a case series of 13 patients

By Aesthetic Multispecialty Society posted Jul 07, 2020 12:13 PM

  
.
0 comments
0 views

Permalink